ClinicalTrials.gov
public full text
Public Domain
Losartan in Treating Patients With Idiopathic Pulmonary Fibrosis
RATIONALE: Losartan may be effective in treating patients with idiopathic pulmonary fibrosis. PURPOSE: This clinical trial is studying the side effects of losartan and to see how well it works in treating patients with idiopathic pulmonary fibrosis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy of Losartan in Preventing Progression of COPD#1171003
- Randomized, Double-blind Study for the Evaluation of the Effect of Losartan Versus Placebo on Aortic Root Dilatation in Patients With Marfan Syndrome Under Treatment With Beta-blockers#1151975
- Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240#918663
- Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients#908180
- Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment#363497
Record · ID 1128084
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive